S100A2 and glioblastoma: S100A2 has been reported to be hypomethylated in GBM (Etcheverry et al., 2010; Martinez and Schackert, 2007) and functions as an inducer of metastasis in vivo in non‐small‐cell lung cancer (Bulk et al., 2009).